SEC Form 3 · accession 0001493152-17-007223
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erik Emerson
Officer — Chief Commercial Officer
Period of report
Jun 22, 2017
Accepted (ET)
Jun 27, 2017 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 600,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted shares of common stock awarded to the reporting person pursuant to the employment offer letter dated June 5, 2017 between the reporting person and the issuer. Such restricted shares shall vest on December 5, 2017. The restricted shares were issued under the issuer's 2014 Long-Term Incentive Plan.